Literature DB >> 20083148

Pancreatic cancer organotypic cultures.

Fieke E M Froeling1, John F Marshall, Hemant M Kocher.   

Abstract

Pancreatic cancer, the fourth most common cause of cancer-related death, is a devastating disease with poor prognosis. Over the last four decades, no effective new treatments have been developed for this cancer. As a result, its prognosis has remained unchanged. Appropriate cancer models, representing all aspects of pancreatic cancer, will enhance our understanding of its biology. In this review we discuss the evolution and merit of organotypic culture models. These co-culture in vitro systems of cancer and stromal cells grown within, or on top of, reconstituted extracellular matrix gels model pancreatic cancer more realistically than 2D systems. Different methodologies are discussed which enable interrogation of various hypotheses examining the tumour-stroma cross-talk. Thus this validated organotypic culture model provides a system, which can be easily manipulated and used to test (novel) treatment options targeting the cancer, the stromal compartment or both, in a physiologically relevant environment. The big challenge for future research is to expand this model further so that its mimicry of the human tumour is more robust. This will increase our understanding of the biology of this aggressive tumour; ultimately resulting in improved therapies and, therefore, a better prognosis. Crown Copyright (c) 2010. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20083148     DOI: 10.1016/j.jbiotec.2010.01.008

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  19 in total

Review 1.  Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.

Authors:  Stacey J Coleman; Jennifer Watt; Prabhu Arumugam; Leonardo Solaini; Elisabeta Carapuca; Mohammed Ghallab; Richard P Grose; Hemant M Kocher
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Screening out irrelevant cell-based models of disease.

Authors:  Peter Horvath; Nathalie Aulner; Marc Bickle; Anthony M Davies; Elaine Del Nery; Daniel Ebner; Maria C Montoya; Päivi Östling; Vilja Pietiäinen; Leo S Price; Spencer L Shorte; Gerardo Turcatti; Carina von Schantz; Neil O Carragher
Journal:  Nat Rev Drug Discov       Date:  2016-09-12       Impact factor: 84.694

Review 3.  A starring role for stellate cells in the pancreatic cancer microenvironment.

Authors:  Minoti V Apte; Jeremy S Wilson; Aurelia Lugea; Stephen J Pandol
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

4.  Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.

Authors:  Vegard Tjomsland; Anna Spångeus; Johanna Välilä; Per Sandström; Kurt Borch; Henrik Druid; Sture Falkmer; Ursula Falkmer; Davorka Messmer; Marie Larsson
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

5.  Multi-Scale Analysis of the Composition, Structure, and Function of Decellularized Extracellular Matrix for Human Skin and Wound Healing Models.

Authors:  Atiya M Sarmin; Nadia El Moussaid; Ratima Suntornnond; Eleanor J Tyler; Yang-Hee Kim; Stefania Di Cio; William V Megone; Oliver Pearce; Julien E Gautrot; Jonathan Dawson; John T Connelly
Journal:  Biomolecules       Date:  2022-06-16

6.  Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.

Authors:  Raghu Kadaba; Hanna Birke; Jun Wang; Steven Hooper; Claudia D Andl; Francesco Di Maggio; Erdinc Soylu; Mohammed Ghallab; Daniel Bor; Fieke Em Froeling; Satyajit Bhattacharya; Anil K Rustgi; Erik Sahai; Claude Chelala; Peter Sasieni; Hemant M Kocher
Journal:  J Pathol       Date:  2013-03-21       Impact factor: 7.996

Review 7.  Preclinical models of pancreatic ductal adenocarcinoma.

Authors:  Chang-Il Hwang; Sylvia F Boj; Hans Clevers; David A Tuveson
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

8.  ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.

Authors:  Jingxuan Yang; Zicheng Zhang; Yuqing Zhang; Xiaoling Ni; Guohua Zhang; Xiaobo Cui; Mingyang Liu; Can Xu; Qiang Zhang; Huiyun Zhu; Jie Yan; Vivian F Zhu; Yusheng Luo; John P Hagan; Zhaoshen Li; Jing Fang; Aminah Jatoi; Martin E Fernandez-Zapico; Lei Zheng; Barish H Edil; Michael S Bronze; Courtney W Houchen; Yi-Ping Li; Min Li
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 22.682

9.  Novel organotypic culture model of cholangiocarcinoma progression.

Authors:  Deanna J W Campbell; Catherine I Dumur; Nadia F Lamour; Jennifer L Dewitt; Alphonse E Sirica
Journal:  Hepatol Res       Date:  2012-05-09       Impact factor: 4.288

10.  RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cells.

Authors:  Ningfeng Fiona Li; Emilios Gemenetzidis; Francis J Marshall; Derek Davies; Yongwei Yu; Kristopher Frese; Fieke E M Froeling; Adam K Woolf; Roger M Feakins; Yoshiki Naito; Christine Iacobuzio-Donahue; David A Tuveson; Ian R Hart; Hemant M Kocher
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.